Demahy v. Actavis, Inc., No. 08-31204

By FindLaw Staff on January 11, 2010 | Last updated on March 21, 2019

In an action based on injuries plaintiff allegedly sustained by taking defendant's drug, a denial of defendant's motion to dismiss is affirmed where the federal regulatory regime governing pharmaceuticals did not preempt state-law failure-to-warn claims against manufacturers of generic drugs.

Read Demahy v. Actavis, Inc., No. 08-31204

Appellate Information

Filed January 8, 2010


Opinion by Judge Higginbotham

Copied to clipboard